Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Plos One|August 11, 2017
CSF profile in primary progressive multiple sclerosis: Re-exploring the basicsAhmed Abdelhak, Tilman Hottenrott, Christoph Mayer, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 29, 2014
Therapeutic plasma exchange in glucocorticosteroid-unresponsive patients with Clinically Isolated SyndromeJohannes Ehler, Sebastian Koball, Martin Sauer, et al.
Plos One|August 6, 2015
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 PatientsJohannes Ehler, Sebastian Koball, Martin Sauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Epilepsy as a predictor of disease progression in multiple sclerosisMatthias Grothe, David Ellenberger, Felix von Podewils, et al.
Journal of Muscle Research and Cell Motility|February 12, 2004
Susceptibility to apoptosis in different murine muscle cell linesMatthias Wittstock, Charlotte Rehfeldt, Gerd Nürnberg, et al.
Therapeutic Advances in Neurological Disorders|January 26, 2012
Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosisPeter Rieckmann, Fedor Heidenreich, Michael Sailer, et al.
Neurobiology of Disease|May 12, 2009
Cerebrospinal fluid biomarkers in multiple sclerosisHayrettin Tumani, Hans-Peter Hartung, Bernhard Hemmer, et al.
In Silico Biology|October 28, 2004
Selecting SNPs for association studies based on population frequencies: a novel interactive tool and its application to polygenic diseasesSteffen Möller, Dirk Koczan, Pablo Serrano-Fernandez, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
Advances in Therapy|April 16, 2022
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECTPeter Rieckmann, Tjalf Ziemssen, Iris-Katarina Penner, et al.
Pageof 18